Circulating Butyrate Attenuates Cetuximab Efficacy in Colorectal Cancer Through EGFR and AMPK–Wip1 Signaling
Drug Design, Development and Therapy · 2026
DOI: 10.2147/dddt.s574116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Jiayao Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Nankai University, Tianjin, People's Republic of China. Hauptthemen laut MEDLINE: Cetuximab, Colorectal Neoplasms, AMP-Activated Protein Kinases, Butyrates. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Nankai University, Tianjin, People's Republic of China.
- Tianjin Institute of Coloproctology, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, People's Republic of China.
- Department of Colorectal Surgery, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, People's Republic of China.
- Human Biology and Society, University of California, Los Angeles, CA, USA.
- TEDA Institute of Biological Sciences and Biotechnology, Nankai University, Tianjin, People's Republic of China.
- Department of Pharmacy, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, People's Republic of China.
ORCID-Profile: Mingqing Zhang, Yijia Wang
Zitieren
APA
Zhang, J., Zhang, M., Wu, X., Jing, H., Li, P., Wang, W., Guo, X., Zhao, Z., Zhu, S., & Wang, Y. (2026). Circulating Butyrate Attenuates Cetuximab Efficacy in Colorectal Cancer Through EGFR and AMPK–Wip1 Signaling. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s574116
Vancouver
Zhang J, Zhang M, Wu X, Jing H, Li P, Wang W, et al. Circulating Butyrate Attenuates Cetuximab Efficacy in Colorectal Cancer Through EGFR and AMPK–Wip1 Signaling. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s574116
BibTeX
@article{Zhang2026,
author = {Zhang, Jiayao and Zhang, Mingqing and Wu, Xiaojing and Jing, Haoren and Li, Peiran and Wang, Wei and Guo, Xi and Zhao, Zhenying and Zhu, Siwei and Wang, Yijia},
title = {Circulating Butyrate Attenuates Cetuximab Efficacy in Colorectal Cancer Through EGFR and AMPK–Wip1 Signaling},
journal = {Drug Design, Development and Therapy},
year = {2026},
doi = {10.2147/dddt.s574116}
}
EUVIMED